http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : H. W. Green (검색결과 12 건)
- 무료
- 기관 내 무료
- 유료
-
-
-
Thompson, I.M.,Cerri, R.L.A.,Kim, I.H.,Green, J.A.,Santos, J.E.P.,Thatcher, W.W. American Dairy Science Association 2010 Journal of dairy science Vol.93 No.9
Objectives were to develop a timed artificial insemination (TAI) resynchronization program to improve pregnancy per AI and to evaluate responses of circulating progesterone and pregnancy-associated glycoproteins in lactating cows. Cows (n=1,578) were presynchronized with 2 injections of PGF<SUB>2α</SUB>, given 14 d apart starting on d 45+/-3 postpartum, followed by Ovsynch [2 injections of GnRH 7 d before and 56h after injection of PGF<SUB>2α</SUB>, TAI 16h after second injection (d 0)]. The Resynch-treated cows received an intravaginal progesterone insert from d 18 to 25, GnRH on d 25, and pregnancy diagnosis on d 32, and nonpregnant cows received PGF<SUB>2α.</SUB>, GnRH 56h later, and TAI 16h later (d 35). The control cows were diagnosed for pregnancy on d 32 and nonpregnant cows received GnRH, PGF<SUB>2α</SUB> 39 d after TAI, GnRH 56h later, and TAI 16h later (d 42). Pregnancy was reconfirmed on d 60 after AI. Ovarian structures were examined in a subset of cows at the time of GnRH and PGF<SUB>2α</SUB> injections. Blood samples for analyses of progesterone and pregnancy-associated glycoproteins were collected every 2 d from d 18 to 30 in 100 cows, and collection continued weekly to d 60 for pregnant cows (n=43). Preenrollment pregnancies per AI on d 32 did not differ for cows subsequently treated as Resynch (45.8%, n=814) and control (45.9%, n=764), and pregnancy losses on d 60 were 6.7 and 4.0%, respectively. Resynchronized service pregnancy per AI (36%, n=441; 39.5%, n=412) and pregnancy losses (6.3 and 6.7%) did not differ for Resynch and control treatments, respectively. Days open for pregnant cows after 2 TAI were less for the Resynch treatment than for the control treatment (96.2+/-0.82 vs. 99.5+/-0.83 d). Cows in the Resynch treatment had more large follicles at the time of GnRH. The number of corpora lutea did not differ between treatments at the time of PGF<SUB>2α</SUB>. Plasma progesterone for pregnant cows was greater for Resynch cows than for control cows (18-60 d; 6.6 vs. 5.3ng/mL), and plasma concentrations of progesterone on d 18 were greater for pregnant cows than for nonpregnant cows (5.3 vs. 4.3ng/mL). Plasma pregnancy-associated glycoproteins during pregnancy were lower for cows in the Resynch treatment compared with control cows on d 39 (2.8 vs. 4.1ng/mL) and 46 (1.3 vs. 3.0ng/mL). Cows pregnant on d 32 that lost pregnancy by d 60 (n=7) had lower plasma concentrations of pregnancy-associated glycoproteins on d 30 than cows that maintained pregnancy (n=36; 2.9 vs. 5.0ng/mL). Pregnancy-associated glycoproteins on d 30 (>0.33ng/mL) were predictive of a positive d 32 pregnancy diagnosis (sensitivity=100%; specificity=90.6%). In conclusion, Resynch and control protocols had comparable pregnancy per AI for first and second TAI services, but pregnancy occurred 3.2 d earlier in the Resynch group because inseminations in the Resynch treatment began 7 d before those in the control treatment. Administration of an intravaginal progesterone insert, or GnRH, or both increased progesterone during pregnancy. Dynamics of pregnancy-associated glycoproteins were indicative of pregnancy status and pregnancy loss.
-
-
Diversification and enrichment of clinical biomaterials inspired by Darwinian evolution
Green, D.W.,Watson, G.S.,Watson, J.A.,Lee, D.J.,Lee, J.M.,Jung, H.S. Elsevier BV 2016 ACTA BIOMATERIALIA Vol.42 No.-
Regenerative medicine and biomaterials design are driven by biomimicry. There is the essential requirement to emulate human cell, tissue, organ and physiological complexity to ensure long-lasting clinical success. Biomimicry projects for biomaterials innovation can be re-invigorated with evolutionary insights and perspectives, since Darwinian evolution is the original dynamic process for biological organisation and complexity. Many existing human inspired regenerative biomaterials (defined as a nature generated, nature derived and nature mimicking structure, produced within a biological system, which can deputise for, or replace human tissues for which it closely matches) are without important elements of biological complexity such as, hierarchy and autonomous actions. It is possible to engineer these essential elements into clinical biomaterials via bioinspired implementation of concepts, processes and mechanisms played out during Darwinian evolution; mechanisms such as, directed, computational, accelerated evolutions and artificial selection contrived in the laboratory. These dynamos for innovation can be used during biomaterials fabrication, but also to choose optimal designs in the regeneration process. Further evolutionary information can help at the design stage; gleaned from the historical evolution of material adaptations compared across phylogenies to changes in their environment and habitats. Taken together, harnessing evolutionary mechanisms and evolutionary pathways, leading to ideal adaptations, will eventually provide a new class of Darwinian and evolutionary biomaterials. This will provide bioengineers with a more diversified and more efficient innovation tool for biomaterial design, synthesis and function than currently achieved with synthetic materials chemistry programmes and rational based materials design approach, which require reasoned logic. It will also inject further creativity, diversity and richness into the biomedical technologies that we make. All of which are based on biological principles. Such evolution-inspired biomaterials have the potential to generate innovative solutions, which match with existing bioengineering problems, in vital areas of clinical materials translation that include tissue engineering, gene delivery, drug delivery, immunity modulation, and scar-less wound healing. Statement of Significance: Evolution by natural selection is a powerful generator of innovations in molecular, materials and structures. Man has influenced evolution for thousands of years, to create new breeds of farm animals and crop plants, but now molecular and materials can be molded in the same way. Biological molecules and simple structures can be evolved, literally in the laboratory. Furthermore, they are re-designed via lessons learnt from evolutionary history. Through a 3-step process to (1) create variants in material building blocks, (2) screen the variants with beneficial traits/properties and (3) select and support their self-assembly into usable materials, improvements in design and performance can emerge. By introducing biological molecules and small organisms into this process, it is possible to make increasingly diversified, sophisticated and clinically relevant materials for multiple roles in biomedicine.
-
Bioinspired materials for regenerative medicine: going beyond the human archetypes
Green, D. W.,Ben-Nissan, B.,Yoon, Kyung-Sik,Milthorpe, B.,Jung, H.-S. The Royal Society of Chemistry 2016 Journal of materials chemistry. B, Materials for b Vol.4 No.14
<P>The evolution of life has given rise to innumerable biomaterials with high levels of functional sophistication and performance among many thousands of different environments. The inexhaustible range of strategies and the intrinsic good design they possess can be readily included in the design of biomedical devices and materials, such as wound healing bandages and antibacterial surface coating implants. We highlight topical examples where various ingenious design strategies from biological models, originating more broadly from zoology and botany, have been appropriated into novel synthetic materials and structures for regenerative and material-based tissue engineering. Bioinspired materials engineering informed and enriched by the vast array of adaptations and strategies in nature, beyond human biology, will be instrumental in the future evolution of new more clinically acceptable pan-functional materials and structures with a broad range of uses in the regenerative sciences.</P>
-
Lin, T.W.,Choi, S.Y.,Kim, Y.H.,Green, M.L.H. Pergamon Press ; Elsevier Science Ltd 2010 Carbon Vol.48 No.9
This study demonstrates the first example of the use of NiI<SUB>2</SUB>-filled carbon nanotubes (CNTs) for the synthesis of GaN nanowires (NWs). Large quantities of single crystal and n-type GaN NWs were synthesized after NiI<SUB>2</SUB>-decorated CNTs reacted with Ga<SUB>2</SUB>O<SUB>3</SUB> in NH<SUB>3</SUB>. Comparatively few short GaN NWs (<1μm) were synthesized in the absence of CNTs, and GaN NWs were found to be synthesized with a reasonable yield using graphite as a reactant. Therefore, CNTs play no role as a template in the growth of NW, but this growth is assisted by NiI<SUB>2</SUB> nanocrystals via a vapour-liquid-solid mechanism in which the presence of carbon materials facilitates the reduction of Ga<SUB>2</SUB>O<SUB>3</SUB> to Ga<SUB>2</SUB>O and Ga, thus providing a constant Ga source during the growth of the NW. Furthermore, the use of NiI<SUB>2</SUB>-filled single wall carbon nanotubes results in a higher NW yield at a low growth temperature (600<SUP>o</SUP>C), indicating that NiI<SUB>2</SUB>-filled single wall CNTs can serve as an effective reactant for the synthesis of GaN NWs.
-
-
-
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
